UCSF researchers call for shift in HIV prevention priorities

October 26, 2000

HIV prevention resources are not allocated in the most cost-effective fashion say researchers at the UCSF Center for AIDS Prevention Studies (CAPS). The UCSF researchers argue that risk reduction funding is disproportionately allocated towards preventing heterosexual transmission of HIV even though the rates of HIV infection among heterosexuals appear to be falling. Conversely, the rates of HIV infection for men who have sex with men (MSMs) have remained stable and may even be increasing.

The researchers also call for a shift from the current focus on HIV case-based reporting which gives "a window on the past" to an emphasis on sentinel surveillance systems that could provide "a much needed window on the future."

The call for the reallocation of risk reduction resources and for the United States to finance long-term HIV surveillance systems of high-risk populations are contained in a paper published in the October 28, 2000 issue of Science.

"If you look at AIDS cases, there is decline in cases among MSMs and an increase in heterosexual cases. However, if you look at the incidence of HIV, meaning the rate of new infections, and the prevalence of HIV, meaning the proportion of individuals in a population infected with the disease, you get a different picture. There seems to be a decline among heterosexuals and stable or increasing rates among MSMs," said Joseph A. Catania, PhD, lead author and assistant professor of medicine with UCSF CAPS. "Unfortunately, our focus has been on AIDS cases which gives a picture five to ten years out of phase with the epidemic. Frankly, we've lost track of the disease," added Catania.

The paper notes that MSMs accounted for 46% of AIDS cases in 1999 and yet received only 28% of HIV risk reduction funding. Meanwhile, risk reduction for heterosexuals accounted for 31% of the spending even though heterosexual transmission accounted for just 17% of U.S. AIDS cases. These funding priorities make sense if the HIV epidemic is increasing among heterosexuals and declining among MSMs. The authors argue that this is not the case. The paper cites data showing that HIV prevalence and incidence among MSMs declined in the latter part of the 1980s. However, over the last ten years, incidence among MSMs has remained constant at one to two percent and there is strong evidence that prevalence of HIV for MSMs has also remained stable in the 1990s. Catania noted, "Prevalence did decline even when incidence was stable because of high death rates. Now HAART (Highly active antiretroviral therapy) has brought the death rates down."

The authors also cite data showing that the prevalence of HIV for heterosexuals, which has always been low (less than one percent), has decreased over the last ten years. This decrease along with reported behavior change, such as increased condom use, suggest that incidence of HIV among heterosexuals is also declining. Also, a downward trend in incidence of HIV among heterosexuals is consistent with observed declines in syphilis in the general population. The researchers observe that current prevention resource allocations are not consistent with the trends in the spread of HIV disease.

In addition, the researchers point out the difficulties faced in knowing how to allocate prevention resources optimally in the absence of long-term surveillance systems that incorporate the current advances in scientific sampling. According to Catania, at least four large surveys of MSMs and four large surveys of high-risk heterosexual populations are needed over the next ten years to chart accurately the direction of the epidemic.
-end-
The UCSF Center for AIDS Prevention Studies is part of the UCSF AIDS Research Institute. Co-authors are Stephen F. Morin PhD, director of the Policy Center, UCSF AIDS Research Institute; Jesse Canchola, MS, UCSF senior statistician, CAPS; Lance Pollack, PhD, UCSF specialist, CAPS; Jason Chang, MS, UCSF assistant statistician, CAPS; and Thomas J. Coates, PhD, UCSF professor of medicine and executive director of UCSF AIDS Research Institute.

University of California - San Francisco

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.